Short-term serotonergic but not noradrenergic antidepressant administration reduces attentional vigilance to threat in healthy volunteers

Article English OPEN
Murphy, Susannah E ; Yiend, Jenny ; Lester, Kathryn J ; Cowen, Philip J ; Harmer, Catherine J (2009)
  • Publisher: Oxford University Press
  • Related identifiers: doi: 10.1017/S1461145708009164
  • Subject: B
    mesheuropmc: behavioral disciplines and activities | mental disorders

Anxiety is associated with threat-related biases in information processing such as heightened attentional vigilance to potential threat. Such biases are an important focus of psychological treatments for anxiety disorders. Selective serotonin reuptake inhibitors (SSRIs) are effective in the treatment of a range of anxiety disorders. The aim of this study was to assess the effect of an SSRI on the processing of threat in healthy volunteers. A selective noradrenergic reuptake inhibitor (SNRI), which is not generally used in the treatment of anxiety, was used as a contrast to assess the specificity of SSRI effects on threat processing. Forty-two healthy volunteers were randomly assigned to 7 d double-blind intervention with the SSRI citalopram (20 mg/d), the SNRI reboxetine (8 mg/d), or placebo. On the final day, attentional and interpretative bias to threat was assessed using the attentional probe and the homograph primed lexical decision tasks. Citalopram reduced attentional vigilance towards fearful faces but did not affect the interpretation of ambiguous homographs as threatening. Reboxetine had no significant effect on either of these measures. Citalopram reduces attentional orienting to threatening stimuli, which is potentially relevant to its clinical use in the treatment of anxiety disorders. This finding supports a growing literature suggesting that an important mechanism through which pharmacological agents may exert their effects on mood is by reversing the cognitive biases that characterize the disorders that they treat. Future studies are needed to clarify the neural mechanisms through which these effects on threat processing are mediated.
  • References (60)
    60 references, page 1 of 6

    Beck AT, Emery G, Greenberg R (1985). Anxiety Disorders and Phobias : A Cognitive Perspective. New York : Basic.

    Birbaumer N, Grodd W, Diedrich O, Klose U, Erb M, Lotze M, Schneider F, Weiss U, Flor H (1998). fMRI reveals amygdala activation to human faces in social phobics. Neuroreport 9, 1223-1226.

    Breiter HC, Etcoff NL, Whalen PJ, Kennedy WA, Rauch SL, Buckner RL, Strauss MM, Hyman SE, Rosen BR (1996). Response and habituation of the human amygdala during visual processing of facial expression. Neuron 17, 875-887.

    Buss AH, Durkee A (1957). An inventory for assessing different kinds of hostility. Journal of Consulting Psychology 21, 343-349.

    Clark DM, Salkovskis PM, Ost LG, Breitholtz E, Koehler KA, Westling BE, Jeavons A, Gelder M (1997). Misinterpretation of body sensations in panic disorder. Journal of Consulting Psychology 65, 203-213.

    Cooper RM, Langton SR (2006). Attentional bias to angry faces using the dot-probe task? It depends when you look for it. Behavioural Research Therapy 44, 1321-1329.

    Davis M, Whalen PJ (2001). The amygdala : vigilance and emotion. Molecular Psychiatry 6, 13-34.

    Dhillon S, Scott LJ, Plosker GL (2006). Escitalopram : a review of its use in the management of anxiety disorders. CNS Drugs 20, 763-790.

    Eysenck MW (1992). Anxiety : the Cognitive Perspective. London : Lawrence Erlbaum Associates.

    Eysenck MW (1997). Anxiety and Cognition. London : Lawrence Erlbaum Associates.

  • Metrics
    0
    views in OpenAIRE
    0
    views in local repository
    32
    downloads in local repository

    The information is available from the following content providers:

    From Number Of Views Number Of Downloads
    Sussex Research Online - IRUS-UK 0 32
Share - Bookmark